AGREEMENT OF LEASE BY AND BETWEEN NOVAPARK LLC Landlord, and ANGION BIOMEDICA CORP. Tenant.Agreement of Lease • March 4th, 2014 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2014 Company Industry JurisdictionAGREEMENT OF LEASE (this “Lease”), made the day of June, 2011, by and between NOVAPARK (“Landlord”), a Delaware limited liability company, having an office at c/o Dr. Itzhak Goldberg, 400 Kelby Street, Fort Lee, New Jersey 07024, and ANGION BIOMEDICA, a Delaware corporation, having an address at 1050 Stewart Ave, Garden City, New York (“Tenant”).
ANGION BIOMEDICA CORPORATION EMPLOYMENT, CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENTInformation and Invention Assignment Agreement • March 4th, 2014 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2014 Company Industry JurisdictionAs a condition of my employment with Angion Biomedica Corporation. (“Angion”), and in consideration of my employment with Angion and my receipt of the compensation now and hereafter paid to me by Angion, I agree to the following:
CONSULTING AGREEMENTConsulting Agreement • March 4th, 2014 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2014 Company Industry JurisdictionWHEREAS, the Consultant desires to continue to provide certain consulting and related services to the Company related to administration of the Company (acting CEO)
ANGION BIOMEDICA CORPORATION EMPLOYMENT, CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENTInvention Assignment Agreement • March 4th, 2014 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2014 Company Industry JurisdictionAs a condition of my employment with Angion Biomedica Corporation. (“Angion”) , and in consideration of my employment with Angion and my receipt of the compensation now and hereafter paid to me by Angion, I agree to the following:
ANGION BIOMEDICA CORPORATION EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTION ASSIGNMENT AGREEMENTEmployee Confidential Information and Invention Assignment Agreement • March 4th, 2014 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2014 Company Industry JurisdictionAs a condition of my employment with Angion Biomedica Corporation (“Angion”), and in consideration of my employment with Angion and my receipt of the compensation now and hereafter paid to me by Angion, I agree to the following:
LEASE Landlord, TO ANGION BIOMEDICA CORPORATION Tenant.Angion Biomedica Corp. • March 4th, 2014 • Pharmaceutical preparations • New Jersey
Company FiledMarch 4th, 2014 Industry JurisdictionThe Land affected by the Within Instrument Lies in Block 4502 on the Tax Map of the Borough of Fort Lee, County of Bergen (Tax Lots 1 and 2).
INVENTION ASSIGNMENT AGREEMENTInvention Assignment Agreement • March 4th, 2014 • Angion Biomedica Corp. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2014 Company Industry JurisdictionAs a condition of my part-time employment with Angion Biomedica Corporation. (“Angion”), and in consideration of my employment with Angion and my receipt of the compensation now and hereafter paid to me by Angion, I agree to the following:
AMENDED, RESTATED AND CONSOLIDATED UNSECURED PROMISSORY NOTEAngion Biomedica Corp. • March 4th, 2014 • Pharmaceutical preparations
Company FiledMarch 4th, 2014 IndustryTHIS AMENDED, RESTATED AND CONSOLIDATED UNSECURED PROMISSORY NOTE (this “Note”) is made and entered into by and between ITZHAK D. GOLDBERG, an individual (the “Maker”), and ANGION BIOMEDICA CORP., a Delaware corporation (the “Holder”). The Holder is the holder of that certain Unsecured Promissory Note dated January 5, 2009, in the original principal amount of Three Hundred Thousand U.S. Dollars (USD $300,000) made by the Maker and payable to the Holder (the “2009 Note”). The Maker and the Holder desire to amend, restate and consolidate the 2009 Note in its entirety with the additional sums advanced hereunder and to reflect a change in the interest rate and terms of payment of the 2009 Note.